Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
September 17, 2015
The New York Attorney General sent cease-and-desist letters to manufacturers of devil’s Claw supplements, saying DNA barcoding tests revealed that instead of containing the devil’s claw strain Harpagophytum procumbens, it contained the strain Harpagophytum zeyheri.
Schneiderman’s office said the zeyheri species is less desirable. The natural products industry disagrees.
Watch this INSIDER TV news desk to get the industry’s take.
You May Also Like
Dr. Mercola allegedly plans to introduce psychic advisor to followersMar 1, 2024
The Vitamin Shoppe general counsel criticizes NY age-restriction lawMar 1, 2024
Is kratom a safe life-giver or a dangerous life-taker?Mar 1, 2024
Patents can offer supplement brands competitive advantageMar 1, 2024